Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · Real-Time Price · USD

8.97

+0.29 (3.34%)

At close: Feb 18, 2026, 4:00 PM EST

9.14

+0.17 (1.90%)

After-hours: Feb 18, 2026, 7:24 PM EST

Fennec Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	306	174	303	252	114	192
Market Cap Growth	71.82%	-42.68%	20.14%	120.31%	-40.49%	48.91%
Enterprise Value	304	165	316	247	95	159
Last Close Price	8.97	6.32	11.22	9.60	4.40	7.45
Forward PE	17.93	-	90.85	-	-	8.87
PS Ratio	7.90	3.65	14.25	164.24	-	1131.07
PB Ratio	-	-29.57	-26.06	-98.13	7.26	6.61
P/TBV Ratio	-	-	-	-	7.26	6.61
P/OCF Ratio	-	6.44	-	-	-	-
EV/Sales Ratio	7.83	3.48	14.88	160.94	-	935.98
EV/EBITDA Ratio	-	45.94	-	-	-	-
EV/EBIT Ratio	-	64.41	-	-	-	-
Debt / Equity Ratio	-4.31	-3.29	-2.66	-9.69	0.32	-
Debt / EBITDA Ratio	-	5.37	-	-	-	-
Net Debt / Equity Ratio	0.57	1.24	-1.52	-0.44	-1.02	-1.04
Net Debt / EBITDA Ratio	0.59	-2.03	-	-	-	-
Asset Turnover	0.72	1.32	0.79	0.06	-	0.01
Inventory Turnover	1.48	1.98	0.92	-	-	-
Quick Ratio	4.21	5.71	2.92	5.49	12.76	12.93
Current Ratio	4.69	6.38	3.56	5.80	13.54	13.39
Return on Equity (ROE)	-	-	-	-359.22%	-77.36%	-88.45%
Return on Assets (ROA)	-5.39%	4.47%	-29.67%	-57.21%	-39.99%	-49.07%
Return on Capital Employed (ROCE)	-11.80%	6.80%	-66.10%	-101.20%	-83.00%	-61.50%
Earnings Yield	-2.27%	-0.25%	-5.30%	-9.41%	-15.16%	-9.42%
Buyback Yield / Dilution	-1.25%	-2.71%	-1.14%	-1.03%	-9.71%	-19.14%

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q